Zeb1 mediates EMT/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition.

Autor: Schwab A; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., Rao Z; Michael Popp Institute and Center for Molecular Biosciences (CMBI), University of Innsbruck, Innsbruck, Austria., Zhang J; Michael Popp Institute and Center for Molecular Biosciences (CMBI), University of Innsbruck, Innsbruck, Austria., Gollowitzer A; Michael Popp Institute and Center for Molecular Biosciences (CMBI), University of Innsbruck, Innsbruck, Austria., Siebenkäs K; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., Bindel N; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., D'Avanzo E; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., van Roey R; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., Hajjaj Y; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., Özel E; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., Armstark I; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., Bereuter L; Michael Popp Institute and Center for Molecular Biosciences (CMBI), University of Innsbruck, Innsbruck, Austria., Su F; Michael Popp Institute and Center for Molecular Biosciences (CMBI), University of Innsbruck, Innsbruck, Austria., Grander J; Michael Popp Institute and Center for Molecular Biosciences (CMBI), University of Innsbruck, Innsbruck, Austria., Bonyadi Rad E; Michael Popp Institute and Center for Molecular Biosciences (CMBI), University of Innsbruck, Innsbruck, Austria., Groenewoud A; Experimental Renal and Cardiovascular Research, Department of Nephropathology, Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Engel FB; Experimental Renal and Cardiovascular Research, Department of Nephropathology, Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Bell GW; Whitehead Institute for Biomedical Research, Cambridge, MA, USA., Henry WS; Whitehead Institute for Biomedical Research, Cambridge, MA, USA.; Dept. of Biology, MIT, Cambridge, MA, USA., Angeli JPF; Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg, Würzburg, Germany., Stemmler MP; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany., Brabletz S; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Koeberle A; Michael Popp Institute and Center for Molecular Biosciences (CMBI), University of Innsbruck, Innsbruck, Austria. andreas.koeberle@uibk.ac.at., Brabletz T; Department of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany. thomas.brabletz@fau.de.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Bavarian Cancer Research Center (BZKF), Erlangen, Germany. thomas.brabletz@fau.de.

Publikováno v: Nature cell biology [Nat Cell Biol] 2024 Sep; Vol. 26 (9), pp. 1470-1481. Date of Electronic Publication: 2024 Jul 15.

Synthesis of Zn2SnO4 powders via hydrothermal method for ceramic targets

Autor: Tuncolu, İ.G., Aciksari, C., Suvaci, E., Ozel, E., Rembeza, S.I., Rembeza, E.S., Plotnikova, E.Yu., Kosheleva, N.N., Svistova, T.V.

Publikováno v: In Journal of the European Ceramic Society November 2015 35(14):3885-3892

Sarcopenia, frailty prevalence, and related factors in patients with stroke: A cross-sectional analytical study from Turkey.

Autor: Koca TT, Berk E, Özel E, Yılmaz AS, Ertürk Z

Publikováno v: Journal of back and musculoskeletal rehabilitation [J Back Musculoskelet Rehabil] 2024; Vol. 37 (5), pp. 1345-1354.

Peculiar word use as a possible trait marker in schizophrenia

Autor: Baskak, Bora, Ozel, E. Tugba, Atbasoglu, E. Cem, Baskak, Seda C.

Publikováno v: In Schizophrenia Research August 2008 103(1-3):311-317

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.